Science
Starlab Space Announces LambdaVision as Latest Customer for its On-Orbit Science Park
HOUSTON, February 24, 2026--Starlab Space LLC, the commercial space station developer expanding access to low Earth orbit research, today announced a reservation agreement with LambdaVision, a biotechnology company developing a protein-based artificial retina designed to restore vision for patients with retinal degenerative diseases. The reservation agreement supports LambdaVision’s transition from research to long-term, scalable biomedical production in space and ensures its continued access to
About this update from Voyager Technologies, Inc.
[{"type":"image","alt":"Space Tango and LambdaVision CubeLabs on the International Space Station, containing optimized and automated hardware for layer-by-layer deposition development of LambdaVision’s artificial retina in microgravity. LambdaVision will extend its research and production activities to Starlab as they advance toward space-based commercial manufacturing of protein-based artificial retinas.","displaySize":"","headline":null,"caption":"Space Tango and LambdaVision CubeLabs on the International Space Station, containing optimized and automated hardware for layer-by-layer deposition development of LambdaVision’s artificial retina in microgravity. LambdaVision will extend its research and production activities to Starlab as they advance toward space-based commercial manufacturing of protein-based artificial retinas.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/58a2bf337717a1371279bcf2e31022fc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/qnFgV4of77QsitHt_bXUjg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/58a2bf337717a1371279bcf2e31022fc","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":243,"url":"https://media.zenfs.com/en/business-wire.com/3f305f469dcda8826411e9f0d72230db"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gZq_1rwURVVB0BHIIlx0Sg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/3f305f469dcda8826411e9f0d72230db","width":480,"height":243}}},{"type":"text","content":"LambdaVision will extend its research and production activities to Starlab as they advance toward space-based commercial manufacturing of protein-based artificial retinas.","length":171,"tagName":"p","attribs":{}},{"type":"text","content":"HOUSTON, February 24, 2026--(BUSINESS WIRE)--Starlab Space LLC, the commercial space station developer expanding access to low Earth orbit research, today announced a reservation agreement with LambdaVision, a biotechnology company developing a protein-based artificial retina designed to restore vision for patients with retinal degenerative diseases. T...